Stock Supply Interruption: Angeliq December 10, 2020

Please refer to the letter from BAYER (Pty) Ltd regarding erratic supply of Angeliq for the period of March 2021.
A substitute will need to be given to patients on this drug.

 

Posted in

Other News

FIGO masterclass series – developing a better understanding of PCOS

This masterclass series, organised by FIGO’s Committee on Reproductive Medicine, Endocrinology and Infertility, highlights that polycystic ovary syndrome…

Journal Article Summary Service April 2022

4 April JASS 2022 PDF

Journal Article Summary Service March 2022

3 March JASS 2022